<?xml version="1.0" encoding="UTF-8"?>
<ref id="rmv2143-bib-0092">
 <label>92</label>
 <mixed-citation publication-type="miscellaneous" id="rmv2143-cit-0092">
  <string-name>
   <surname>Hoffmann</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Schroeder</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Kleine‐Weber</surname>
   <given-names>H</given-names>
  </string-name>, 
  <string-name>
   <surname>Müller</surname>
   <given-names>MA</given-names>
  </string-name>, 
  <string-name>
   <surname>Drosten</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Pöhlmann</surname>
   <given-names>S</given-names>
  </string-name>. Nafamostat Mesylate Blocks Activation of SARS‐CoV‐2: New Treatment Option. The Currently Unfolding Coronavirus Pandemic Threatens Health Systems and Economies. 2020. 
  <ext-link ext-link-type="uri" xlink:href="http://aac.asm.org/" xmlns:xlink="http://www.w3.org/1999/xlink">http://aac.asm.org/</ext-link>. Accessed April 27, 2020.
 </mixed-citation>
</ref>
